Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Ontrak, Inc.
  6. News
  7. Summary
    OTRK   US6833731044

ONTRAK, INC.

(OTRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

The Law Offices of Frank R. Cruz : Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ontrak, Inc. (OTRK)

04/29/2021 | 11:01am EDT

The Law Offices of Frank R. Cruz reminds investors of the upcoming May 3, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Ontrak, Inc. (“Ontrak” or the “Company”) (NASDAQ: OTRK) securities between November 5, 2020 and February 26, 2021, inclusive (the “Class Period”).

If you are a shareholder who suffered a loss, click here to participate.

On March 1, 2021, Ontrak issued a press release announced preliminary financial results for fourth quarter and full year 2020. Therein, the Company stated that its largest customer had terminated its contract with Ontrak, effective June 26, 2021. The Company stated that this customer “evaluated Ontrak on a provider basis” and “[a]s such, the customer evaluated [Ontrak’s] performance based on [its] ability to achieve the lowest possible cost per medical visit, and not on [its] clinical outcomes data or medical cost savings.” The Company also stated that “the coaching model which Ontrak has pioneered for over a decade was seen by the customer to be less relevant to their performance metrics.”

On this news, the Company’s share price fell $27.32, or more than 46%, to close at $31.62 per share on March 1, 2021, thereby injuring investors.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Ontrak’s largest customer evaluated the Company on a provider basis, valuing Ontrak’s performance based on achieving the lowest cost per medical visit rather than clinical outcomes or medical cost savings; (2) that, as a result, Ontrak’s largest customer did not find the Company’s program to be effective and was reasonably likely to terminate its contract with Ontrak; (3) that, because this customer accounted for a significant portion of the Company’s revenue, the loss of the customer would have an outsized impact on Ontrak’s financial results; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased or otherwise acquired Ontrak securities during the Class Period, you may move the Court no later than May 3, 2021 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.


ę Business Wire 2021
All news about ONTRAK, INC.
05/20ONTRAKá : Optima Health Selects Ontrak for all Medicare and Medicaid Business
BU
05/11ONTRAKá : to Present at the 2021 RBC Capital Markets Global Healthcare Conferenc..
BU
05/10ONTRAKá : B. Riley Lowers Ontrak's PT to $58 from $73 on Lower Estimates, Keeps ..
MT
05/06ONTRAKá : Earnings Flash (OTRK) ONTRAK Posts Q1 Revenue $28.7M, vs. Street Est o..
MT
05/06ONTRAKá : Earnings Flash (OTRK) ONTRAK Reports Q1 Loss $-0.17, vs. Street Est of..
MT
05/06ONTRAK, INC.á : Results of Operations and Financial Condition, Financial Stateme..
AQ
05/06ONTRAKá : Announces 2021 First Quarter Financial Results
BU
05/06ONTRAKá : Management's Discussion and Analysis of Financial Condition and Result..
AQ
05/05ONTRAKá : Declares Quarterly Dividend on 9.50% Non-Convertible Series A Preferre..
BU
05/04ONTRAKá : Landmark Behavioral Health Treatment Effect Study Shows 64% Reduction ..
BU
More news
Financials (USD)
Sales 2021 84,2 M - -
Net income 2021 -41,5 M - -
Net Debt 2021 - - -
P/E ratio 2021 -15,6x
Yield 2021 -
Capitalization 617 M 617 M -
Capi. / Sales 2021 7,33x
Capi. / Sales 2022 5,02x
Nbr of Employees 724
Free-Float 40,3%
Chart ONTRAK, INC.
Duration : Period :
Ontrak, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ONTRAK, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 34,17 $
Average target price 40,86 $
Spread / Average Target 19,6%
EPS Revisions
Managers and Directors
NameTitle
Jonathan E. Mayhew Chief Executive Officer
Curt Medeiros President & Chief Operating Officer
Brandon H. LaVerne Chief Financial Officer
Terren S. Peizer Executive Chairman
Julia Wright Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ONTRAK, INC.-44.70%606
CVS HEALTH CORPORATION22.59%110 236
HCA HEALTHCARE, INC.25.35%68 165
REDE D'OR SÃO LUIZ S.A.0.73%26 874
LABORATORY CORPORATION OF AMERICA HOLDINGS29.62%25 763
FRESENIUS MEDICAL CARE AG & CO. KGAA0.79%24 048